Search for a command to run...
Based in Western Europe, I'm a tech enthusiast with a track record of successfully leading digital projects for both local and global companies.
No comments yet. Be the first to comment.
Navigate women's health with confidence: science-backed articles on hormones, nutrition, fitness, advocacy, and real stories. no hype, just clarity and actionable insights for evidence-seeking women.
“Low‑carb fixed my hormones” sounds like one change with a predictable result. In research and in real life, it usually isn’t. People use “low‑carb” to mean at least four different things: swapping refined carbs for higher‑fiber foods, eating ketogen...
Sawdust is still stuck on my hands. The tile feels cool under my feet. My backpack is half packed, and the “usual” corner where I train is blocked by a plank that seemed like a good idea two hours ago. Same week on the calendar, same motivation in th...
The air in my garage gym in France smelled like tilia while I was stretching. Soft, almost sweet. The kind of smell that makes your shoulders drop by one millimeter, just because life feels normal for a second. Then I sat back down for a remote workd...
Dust still in my shoes from a hike outside Lisbon, my lungs feel clear and my legs feel loud in the best way. Wind in the trees. That clean outdoor smell stuck in my clothes. Then I’m back at my remote work corner and everything goes quiet, almost to...
The screen glow is a bit brutal at 7am. Slack is already awake. Little green checkmarks. A sweaty selfie or two. And suddenly the movement that was supposed to be for me starts to feel like something that can be evaluated, stored, and maybe reused la...
Clinical trials increasingly highlight “diverse enrollment” as proof that results apply to everyone. But a baseline table with more categories is not the same as evidence you can use when the question is specific: What are the benefits and harms for ...
Two menstruating women can eat similarly “iron-conscious” diets, follow the same grocery list, and still end up with very different ferritin trends. One stays stable. The other slowly drifts down until training feels harder, recovery slows, or routine labs finally flag “low ferritin.” That mismatch often gets blamed on diet. The evidence points somewhere more useful: iron status is governed by a balance sheet: intake × absorption − losses, and absorption and losses can vary enough to outweigh a “good diet.” (NIH ODS iron fact sheet; IOM DRI, 2001)
This article is here to replace guesswork with a physiology-first framework that matches what many women report in clinic: it’s possible to do everything “right” and still run low. In clinic and in the literature, the pattern is consistent: hemoglobin can look “fine” while ferritin lags—so we track both. Instead of treating ferritin like a virtue score, we’ll treat it like an accounting problem, with levers you can measure, track, and discuss with a clinician.
Here’s what you’ll gain as you read:
Along the way, major sections are labeled by evidence strength (gold-standard vs mechanistic/estimates), and you’ll get practical tools: symptom signals to document, a PBAC-style tracking option (Higham et al., 1990), and specific questions to bring to appointments, so “my labs are normal” doesn’t end the conversation when your iron balance sheet says otherwise.
If hemoglobin is normal but ferritin is trending down, the most efficient next step is usually to audit the “losses” side first, because it can dominate the equation even with a strong diet:
1) Menstrual losses: Does bleeding interfere with quality of life (NICE NG88), or do you have objective signals consistent with heavier loss?
2) Donation losses: Any whole-blood donations in the last few months (or frequent donation over time)?
3) Then zoom in on absorption context (timing, inhibitors/enhancers) and intake (heme vs non-heme sources).
That order mirrors what often creates the biggest mismatch between “my diet looks good” and “my ferritin keeps dropping.”
A useful model is:
intake × absorption − losses
If the main issue is losses, simply adding more non-heme iron foods can be too small to change the math. If absorption is blocked, higher intake won’t reliably raise stores. Absorption is also not a fixed percentage. Inhibitors and enhancers can shift how much you absorb enough to matter (IOM DRI, 2001 bioavailability assumptions). For example: taking calcium with an iron-rich meal, or having tea/coffee with meals (polyphenols), can lower non-heme iron absorption, while vitamin C paired with non-heme iron can increase it. (Mechanistic + guideline assumptions: IOM DRI, 2001; NIH ODS iron fact sheet.) This is why someone can “do everything right” and still run low: the equation can work against you even with a solid diet (NIH ODS).
Menstrual blood loss spans a wide range. Classic objective measurement work suggests an average around ~30 to 40 mL per cycle, with a historically used research threshold for heavy menstrual bleeding of >80 mL/cycle (Hallberg & Nilsson, 1964).
For ballpark planning, a commonly used approximation is ~0.5 mg iron per 1 mL whole blood (useful for rough math, not self-diagnosis). This varies with hemoglobin concentration and hematocrit, so treat it as an estimate rather than a precise conversion.
| Approx. menstrual blood loss | Approx. iron loss per cycle* |
| 30–40 mL (around average) | ~15–20 mg |
| 80–120 mL (heavy range) | ~40–60 mg |
*Rule-of-thumb estimate using ~0.5 mg iron/mL whole blood; varies by individual blood parameters.
Menstruation isn’t the only time the equation shifts. Across the female timeline, repeated or clustered exposures can raise the “losses” term without changing what someone eats.
Several windows commonly tilt the balance sheet toward depletion:
Guidance also emphasizes that “heavy” is often defined by impact on quality of life, not a milliliter cutoff (NICE NG88). Another major amplifier is frequent blood donation, which shows a dose–response relationship with low iron stores in donor cohorts (Cable et al., Transfusion, 2011; RISE).
NICE defines heavy menstrual bleeding (HMB) as bleeding that interferes with physical, social, emotional, and/or material quality of life, whether or not it can be measured in mL (NICE NG88). The older >80 mL/cycle threshold provides research context but isn’t how most care decisions begin (Hallberg & Nilsson, 1964; NICE NG88).
If you’re told “your Hb is fine, so it’s normal,” bring concrete signals rather than “pretty heavy.” Studies on symptom predictors support documenting:
These are prompts for evaluation and documentation, not a diagnosis.
If subjective descriptions aren’t landing, a structured log can help. The Pictorial Blood Loss Assessment Chart (PBAC) scores pad/tampon saturation and clots. In the original work, PBAC ≥100 was commonly used to approximate heavy bleeding (some settings use ≥150), but versions and cut points vary (Higham et al., 1990). A key limitation is that absorbency differs by product and brand, so PBAC works best as trend + triage support, not precise measurement.
Practical takeaway: track PBAC for one full cycle (or the heaviest portion) and bring it to your appointment to reduce ambiguity.
A standard whole-blood donation removes roughly ~200 to 250 mg of iron (American Red Cross). Reviews note menstruating/premenopausal women are disproportionately affected because baseline ferritin tends to be lower and menstrual losses continue between donations (Kiss & Vassallo, Transfusion, 2018). Donation screening primarily checks hemoglobin, which can remain “acceptable” even when ferritin is low, so passing the finger-prick does not confirm healthy iron reserves (Kiss & Vassallo, 2018).
Across donor studies, hemoglobin rebounds faster than iron stores, so ferritin can lag for months (Kiss & Vassallo, 2018). In the HEIRS trial, donors assigned to oral iron recovered iron indices faster than those receiving no iron/placebo, especially when starting ferritin was low (Kiss et al., Transfusion, 2015). The STRIDE trial tested low-dose elemental iron (19 mg or 38 mg daily) and found improved iron status and fewer deficiencies versus no iron (Cable et al., Transfusion, 2016). Many blood services discuss time-limited, low-dose supplementation after donation (ARC guidance aligns with similar dose ranges).
Practical takeaway: if donation is part of your life, consider “panel, not point” monitoring. A minimal, concrete plan to discuss with your clinician is: check ferritin + transferrin saturation (TSAT) before your next donation (or at your next lab draw), and re-check 8–12 weeks after donating—especially if ferritin was low at baseline or if you donate regularly. Don’t assume a normal Hb screen means iron stores have recovered.
If your ferritin has fallen despite an “iron-conscious” diet, the evidence gives a more useful explanation than willpower: iron status behaves like a balance sheet (intake × absorption − losses), and absorption and losses can vary enough to dominate the outcome (NIH ODS; IOM DRI, 2001). That’s why single fixes often disappoint, and why normal hemoglobin can still coexist with depleted stores.
The most actionable next steps are often the most overlooked: identify likely loss drivers and bring shareable data. Track cycle bleeding with concrete signals or a PBAC-style log (Higham 1990). If you donate blood, remember that Hb screening can miss low ferritin while stores recover slowly. Trials like HEIRS and STRIDE suggest time-limited, low-dose iron can speed repletion after donation (Kiss 2015; Cable 2016).
Which lever seems most relevant for you right now: absorption, menstrual loss, donation frequency, or lab follow-up, and what would you want to ask at your next appointment?